Insitro is revolutionizing pharmaceutical R&D by leveraging machine learning for drug discovery.
Sign up today and learn more about Insitro Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Insitro Stock
Over the past decades, developing drugs has become increasingly more difficult and expensive, leaving many patients with significant unmet need. A constellation of technologies now allows us to construct, perturb, and observe biological model systems in the laboratory, allowing the generation of biomolecular data at unprecedented breadth and scale. At the same time, the tools of data science and machine learning are now solving problems previously thought to be decades away from solution. We aim to combine these technologies to develop a new approach to drug development that might help us cure more people, sooner, and at a much lower cost.
Founder & CEO